A new drug being developed by Pfizer offers the possibility of nearly putting an end to deaths from COVID-19.
When given within five days of the onset of symptoms, the antiviral therapy called Paxlovid, prevented almost 90% of deaths from COVID-19 compared to a placebo, a Pfizer study found.
By the end of the year, the company plans to complete two other studies of the pill, which is given twice a day for five days. Pfizer plans to submit the study data as part of its ongoing rolling submission to the Food and Drug Administration as soon as possible.
Condemnation from Sanders and his colleagues to follow in due course?